Diaceutics’ CEO Ryan Keeling and CFO Nick Roberts provided an update on the Company's H1 2026 results on September 22nd. Please fill in the form to gain access to the presentation.
Please allow up to 24 hours for the link to the presentation to be sent after you complete the form.
Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.
READY TO DO COMMERCIALIZATION DIFFERENTLY?
Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.
.png)
